Big pharma ’s patent cliff is fast approaching

A of $10.8bn would look hefty for most acquisitions of smallish and newish companies. But for Merck, a drugs giant known as outside America, the money it is spending to buy Prometheus Biosciences, a biotech firm based in California, is relatively small change. In the world of big pharma such deals…#merck #prometheus #crohn #keytruda #pfizer #pharma #seagen #bellushealth #bottomline
Source: Reuters: Health - Category: Consumer Health News Source Type: news